'Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same' in Patent Application Approval Process (USPTO 20190083425)

Source :: Drug Week. April 12, 2019, 393
Publication Year :: 2019
Abstract: 2019 APR 12 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A patent application by the inventors FARR, Stephen J. (Orinda, CA); BOYD, BROOKS (Berkeley, CA), [...]

Subjects :: Drug discovery -- Methods
Brivaracetam -- Methods
Epilepsy -- Methods
Anticonvulsants -- Intellectual property -- Methods
Ethotoin
Vigabatrin
Mephenytoin
Felbamate
Rufinamide
Primidone
Perampanel
Editors
Phenacemide
Lacosamide
Tiagabine
Oxcarbazepine
Zonisamide
Methsuximide
Pharmaceuticals and cosmetics industries

Tools